Skip Navigation Links
Skip Navigation Links

GU - Kidney

GU - Renal Cancer Trials in St. Louis, MO

MATCH: Molecular analysis for therapy choice. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphoma.  EAY131 (NCT02465050)  (MBMC Contact: Missy Kuhn 314-996-5868)  

Randomized Phase III trial of mematine and whole-brain radiotherapy with or without hippocampal avoidance in patients with brain metastases  NRG-CC001 (NCT02360215 )  (MBMC Contact:  Diana Christian 314-996-5888)  (Requires radiation oncologist to undergo training and specialized MRIs - approved at MBMC)

A randomized phase II efficacy assessment of multiple MET kinase Inhibitors (cabozantinib, crizotinib, savolitinib, and sunitinib) in metastatic papillary renal carcinoma (PAPMET)  SWOG S1500 (NTC02751057)  (MBMC Contact:  Missy Kuhn 314-996-5868)



All contents 2007 Heartland Cancer Research St. Louis, MO. All rights reserved. Privacy Policy